EA200100343A3 - Новые гетероциклоалкилбензоциклобутановые и гетероарилбензоциклобутановые производные, способ их получения и содержащие их фармацевтические композиции - Google Patents
Новые гетероциклоалкилбензоциклобутановые и гетероарилбензоциклобутановые производные, способ их получения и содержащие их фармацевтические композицииInfo
- Publication number
- EA200100343A3 EA200100343A3 EA200100343A EA200100343A EA200100343A3 EA 200100343 A3 EA200100343 A3 EA 200100343A3 EA 200100343 A EA200100343 A EA 200100343A EA 200100343 A EA200100343 A EA 200100343A EA 200100343 A3 EA200100343 A3 EA 200100343A3
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- denotes
- oxygen atom
- atom
- inclusive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
В заявке описаны соединения формулы (I)гдеобозначает простую или двойную связь,n обозначает целое число от 1 до 6 включительно,Rи Rобозначают группу, выбранную из ряда, включающего атом водорода, линейную или разветвленную С-Салкильную группу, арильную группу, арилалкильную группу, циклоалкильную группу, циклоалкилалкильную группу, алкенильную группу, алкинильную группу, гетероциклоалкильную группу, гетероциклоалкилалкильную группу, гетероарильную группу и гетероарилалкильную группу,Х обозначает группу, выбранную из ряда, включающего -СН=СН-, атом кислорода, группу S(O), где m обозначает целое число от 0 до 2 включительно, и NR, где Rимеет значения, указанные в описании,Y обозначает СН- или СН-группу в зависимости от того, обозначает липростую связь или двойную связь, или может также обозначать атом кислорода, когда Х обозначает атом кислорода,Т обозначает моноциклическую или полициклическую С-Сциклоалкильную группу, необязательно содержащую в кольцевой системе атом кислорода, атом селена, группу формулы S(O), NRили SiRR, где р, R, Rи R, имеют значения, указанные в описании,их изомеры и аддитивные соли с фармацевтически приемлемой кислотой или основанием. Также описаны лекарственные средства.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0004742A FR2807753B1 (fr) | 2000-04-13 | 2000-04-13 | Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (3)
Publication Number | Publication Date |
---|---|
EA200100343A2 EA200100343A2 (ru) | 2001-10-22 |
EA200100343A3 true EA200100343A3 (ru) | 2002-02-28 |
EA004473B1 EA004473B1 (ru) | 2004-04-29 |
Family
ID=8849212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200100343A EA004473B1 (ru) | 2000-04-13 | 2001-04-12 | Гетероциклоалкилбензоциклобутановые и гетероарилбензоциклобутановые производные и содержащие их фармацевтические композиции |
Country Status (25)
Country | Link |
---|---|
US (1) | US6420413B2 (ru) |
EP (1) | EP1146041B1 (ru) |
JP (1) | JP3761796B2 (ru) |
KR (1) | KR100456795B1 (ru) |
CN (1) | CN1166659C (ru) |
AR (1) | AR028324A1 (ru) |
AT (1) | ATE254102T1 (ru) |
AU (1) | AU777825B2 (ru) |
BR (1) | BR0101444A (ru) |
CA (1) | CA2344255C (ru) |
DE (1) | DE60101177T2 (ru) |
DK (1) | DK1146041T3 (ru) |
EA (1) | EA004473B1 (ru) |
ES (1) | ES2210104T3 (ru) |
FR (1) | FR2807753B1 (ru) |
HK (1) | HK1042477B (ru) |
HU (1) | HUP0101503A3 (ru) |
MX (1) | MXPA01003553A (ru) |
NO (1) | NO318158B1 (ru) |
NZ (1) | NZ511092A (ru) |
PL (1) | PL347056A1 (ru) |
PT (1) | PT1146041E (ru) |
SI (1) | SI1146041T1 (ru) |
TR (1) | TR200302002T4 (ru) |
ZA (1) | ZA200103065B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056769A2 (en) * | 2002-12-20 | 2004-07-08 | Ciba Specialty Chemicals Holding Inc. | Synthesis of amines and intermediates for the synthesis thereof |
US7803894B2 (en) * | 2003-12-05 | 2010-09-28 | 3M Innovatie Properties Company | Coating compositions with perfluoropolyetherisocyanate derived silane and alkoxysilanes |
CN105541662B (zh) * | 2015-12-28 | 2018-04-17 | 云南大学 | 二氢萘类化合物的固相合成方法 |
CN107445835B (zh) * | 2017-07-05 | 2020-09-22 | 江苏师范大学 | 一种1,2-二氢环丁烯并[a]萘衍生物及其前体的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0639374T3 (da) * | 1993-06-28 | 2002-05-06 | American Home Prod | Nye behandlingsmetoder ved anvendelse af phenethylderivater |
US5530013A (en) * | 1994-02-14 | 1996-06-25 | American Home Products Corporation | Venlafaxine in the inducement of cognition enhancement |
JPH09512025A (ja) * | 1994-04-23 | 1997-12-02 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5ht▲下2c▼および5ht▲下2b▼アンタゴニストとしての三環式誘導体 |
US5506270A (en) * | 1995-01-30 | 1996-04-09 | American Home Products Corporation | Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
FR2775687B1 (fr) * | 1998-03-04 | 2000-04-14 | Adir | Nouveaux composes du benzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2000
- 2000-04-13 FR FR0004742A patent/FR2807753B1/fr not_active Expired - Fee Related
-
2001
- 2001-04-06 MX MXPA01003553A patent/MXPA01003553A/es unknown
- 2001-04-10 JP JP2001111169A patent/JP3761796B2/ja not_active Expired - Fee Related
- 2001-04-11 AR ARP010101713A patent/AR028324A1/es unknown
- 2001-04-11 NO NO20011862A patent/NO318158B1/no unknown
- 2001-04-11 BR BR0101444-7A patent/BR0101444A/pt not_active Application Discontinuation
- 2001-04-12 EP EP01400940A patent/EP1146041B1/fr not_active Expired - Lifetime
- 2001-04-12 US US09/833,827 patent/US6420413B2/en not_active Expired - Fee Related
- 2001-04-12 SI SI200130044T patent/SI1146041T1/xx unknown
- 2001-04-12 AT AT01400940T patent/ATE254102T1/de not_active IP Right Cessation
- 2001-04-12 ES ES01400940T patent/ES2210104T3/es not_active Expired - Lifetime
- 2001-04-12 DE DE60101177T patent/DE60101177T2/de not_active Expired - Fee Related
- 2001-04-12 NZ NZ511092A patent/NZ511092A/xx unknown
- 2001-04-12 HU HU0101503A patent/HUP0101503A3/hu unknown
- 2001-04-12 PT PT01400940T patent/PT1146041E/pt unknown
- 2001-04-12 DK DK01400940T patent/DK1146041T3/da active
- 2001-04-12 KR KR10-2001-0019542A patent/KR100456795B1/ko not_active IP Right Cessation
- 2001-04-12 AU AU35187/01A patent/AU777825B2/en not_active Ceased
- 2001-04-12 ZA ZA200103065A patent/ZA200103065B/xx unknown
- 2001-04-12 TR TR2003/02002T patent/TR200302002T4/xx unknown
- 2001-04-12 EA EA200100343A patent/EA004473B1/ru not_active IP Right Cessation
- 2001-04-13 PL PL01347056A patent/PL347056A1/xx not_active Application Discontinuation
- 2001-04-13 CN CNB011163860A patent/CN1166659C/zh not_active Expired - Fee Related
- 2001-04-17 CA CA002344255A patent/CA2344255C/fr not_active Expired - Fee Related
-
2002
- 2002-03-22 HK HK02102196.6A patent/HK1042477B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI906204A0 (fi) | Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi | |
RU2008123839A (ru) | Соединение оксазола и фармацевтическая композиция | |
EA200401609A1 (ru) | Лекарственное средство для лечения диабета | |
ES2044836T3 (es) | Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene. | |
ES2121441T3 (es) | Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco | |
EA200601235A1 (ru) | Производные тиазола | |
HU895609D0 (en) | Process for the preparation of novel 1,4-diazepine derivatives and pharmaceutical compositions containing such compounds | |
HUP0400246A2 (hu) | 1,2,4-Trioxolánt tartalmazó maláriaellenes gyógyszerkészítmények és eljárás az előállításukra és az alkalmazásukra | |
CA2336412A1 (en) | Medicament for treatment of diabetes | |
EP1634874A4 (en) | imidazolidine | |
EA200000792A3 (ru) | Новые пиридиновые соединения, способ их получения и содержащие их фармацевтические композиции | |
EA200100059A3 (ru) | Новые бензолсульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
AR029618A1 (es) | Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos | |
EA200100343A3 (ru) | Новые гетероциклоалкилбензоциклобутановые и гетероарилбензоциклобутановые производные, способ их получения и содержащие их фармацевтические композиции | |
HUP0004588A2 (hu) | Szubsztituált 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-ol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerként, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
EA200200663A1 (ru) | НОВЫЕ СОЕДИНЕНИЯ ОКТАГИДРО-2H-ПИРИДО[1,2-α]ПИРАЗИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ, ИХ СОДЕРЖАЩИЕ | |
EA200000068A3 (ru) | Новые цианоиндольные соединения, являющиеся ингибиторами повторного захвата серотонина, способ их получения и фармацевтические композиции, содержащие их | |
EA200101204A1 (ru) | Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции | |
EA200000374A2 (ru) | Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции | |
EA200200682A1 (ru) | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие | |
EA200100725A3 (ru) | Новые бензотиадиазиновые соединения, способ их получения и их содержащие фармацевтические композиции | |
HUP0202647A2 (hu) | Új arilalkanoilszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
EA200000527A2 (ru) | Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
EA199900600A1 (ru) | Производные пиразола | |
EA200400756A1 (ru) | Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |